Journal Article DKFZ-2023-00099

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2023
Elsevier New York, NY

Cancer cell 41(2), 235-251.e9 () [10.1016/j.ccell.2022.12.007]
 GO

This record in other databases:  

Please use a persistent id in citations: doi:

Abstract: Cancer immunotherapy critically depends on fitness of cytotoxic and helper T cell responses. Dysfunctional cytotoxic T cell states in the tumor microenvironment (TME) are a major cause of resistance to immunotherapy. Intratumoral myeloid cells, particularly blood-borne myeloids (bbm), are key drivers of T cell dysfunction in the TME. We show here that major histocompatibility complex class II (MHCII)-restricted antigen presentation on bbm is essential to control the growth of brain tumors. Loss of MHCII on bbm drives dysfunctional intratumoral tumor-reactive CD8+ T cell states through increased chromatin accessibility and expression of Tox, a critical regulator of T cell exhaustion. Mechanistically, MHCII-dependent activation of CD4+ T cells restricts myeloid-derived osteopontin that triggers a chronic activation of NFAT2 in tumor-reactive CD8+ T cells. In summary, we provide evidence that MHCII-restricted antigen presentation on bbm is a key mechanism to directly maintain functional cytotoxic T cell states in brain tumors.

Keyword(s): CD8 T cell dysfunction ; MHC class II ; NFAT ; TOX ; glioblastoma ; glioma ; macrophages ; microenvironment ; myeloid cells ; osteopontin

Classification:

Note: #EA:D170#LA:D170# / 2023 Feb 13;41(2):235-251.e9 / HI-TRON

Contributing Institute(s):
  1. KKE Neuroimmunologie und Hirntumorimmunologie (D170)
  2. DKTK HD zentral (HD01)
  3. DKFZ -Bayer Healthcare Joint (D220)
  4. KKE Neuroonkologie (B320)
  5. KKE Neuropathologie (B300)
Research Program(s):
  1. 314 - Immunologie und Krebs (POF4-314) (POF4-314)

Appears in the scientific report 2023
Database coverage:
Medline ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 50 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Institute Collections > D170
Public records
Publications database

 Record created 2023-01-16, last modified 2024-02-29



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)